✦ LIBER ✦

Analysis of Proportions in One- or Two-Way Tables with Spoiled Data

✍ Scribed by Prof. B. M. Bennett

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 263 KB
Volume: 29
Category: Article
ISSN: 0323-3847
DOI: 10.1002/bimj.4710290310

No coin nor oath required. For personal study only.

✦ Synopsis

Thia paper diacuseee the analgsh of data on proportions in contingency tables. The Xl 'index of dispersion tpt' (e.g. FISHER, 1954) is developed in these situations and compared with the use of the 'logit' traneformation.An example using OSBOBN'S (1979) data is given, illustrating the estimation of one or more missing observationa.

📜 SIMILAR VOLUMES

On Analysis of Proportions in Tables wit

On Analysis of Proportions in Tables with Spoiled Data

✍ Prof. P. A. Lachenbruch 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 1 views

A Note on Estimation of Several Missing

A Note on Estimation of Several Missing Values in Two Way Classified Data with Many Observations Per Cell

✍ J. Subramani 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB 👁 1 views

Followup radiographic data on patients w

Followup radiographic data on patients with rheumatoid arthritis who participated in a two-year trial of prednisone therapy or placebo

✍ Johannes W. G. Jacobs; Amalia A. Van Everdingen; Suzan M. M. Verstappen; Johanne 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

Anastrozole versus megestrol acetate in

Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma : Results of a survival update based on a combined analysis of data from two mature phase III trials

✍ Aman U. Buzdar; Walter Jonat; Anthony Howell; Stephen E. Jones; Carl P. Blomqvis 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

Medical University of BACKGROUND. This report presents the results of a survival update based on the combined data from two studies that compared the efficacy and tolerability of anastrozole (1 or 10 mg once daily), a selective, nonsteroidal aromatase inhibitor administered orally, and megestrol ace